Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
17.95
Spread: 0.95 (5.588%)
Market Cap: £22.12m
CRTA Live PriceLast checked at - London Stock Exchange

Intraday Cirata Share Chart

Block Listing Return

3 Jun 2025 14:39

RNS Number : 2661L
Cirata PLC
03 June 2025
 

3 June 2025

Cirata plc

("Cirata" or the "Company")

 

Block Listing Return

 

Cirata plc (LSE: CRTA), the data activation platform, provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

 

Name of issuer:

Cirata plc

Name of scheme(s):

i. WANdisco plc UK Enterprise Management Incentive Plan 2012

ii. WANdisco plc UK Unapproved Sub-Plan 2012

iii. WANdisco plc US Sub-Plan 2012

iv. WANdisco plc Long Term Incentive Plan 2013

v. WANdisco plc US Equity Incentive Plan 2013

vi. WANdisco plc UK EMI Sub-plan 2013

vii. Cirata 2023 plan

 

Period of return:

From:

1 December 2024

To:

31 May 2025

Balance of unallotted securities under scheme(s) from previous return:

Ordinary Shares of 10p each as follows:

i. nil

ii. nil

iii. 5,000

iv. 18,333

v. 717,890

vi. 1,392,617

vii. 4,144,167

 

Plus: The amount by which the block scheme(s) has been increased (decreased) since the last return:

i. nil

ii. nil

iii. nil

iv. nil

v. nil

vi. nil

vii. nil

 

Less: Number of securities issued under the scheme(s) during the period:

i. nil

ii. nil

iii. nil

iv. 10,000

v. 35,788

vi. nil

vii. nil

 

Equals: Balance under the scheme(s) of securities not yet issued at the end of the period:

i. nil

ii. nil

iii. 5,000

iv. 8,333

v. 682,102

vi. 1,392,617

vii. 4,144,167

 

Number and class of securities originally admitted and the date of admission:

2,300,000 Ordinary Shares of 10p each on 10 July 2012 split as follows: 

i. 774,850 

ii. 407,260 

iii. 1,117,890

 

3,700,000 Ordinary Shares of 10p each on 16 March 2016 split as follows: 

i. 3,000,000

ii. 200,000

iii. 500,000

 

1,750,000 Ordinary Shares of 10p each on 8 December 2016 split as follows: 

i. 89,296 

ii. 9,890

iii. 468,610

iv. nil

v. 982,204

vi. 200,000

 

2,000,000 Ordinary Shares of 10p each on 7 November 2022 split as follows: 

v. 907,141 

vi. 1,092,859

 

5,000,000 ordinary shares of 10p each on 14 December 2023, split as follows:

vii. 5,000,000

 

Total issued share capital as at the end of this period (including any shares held in Treasury):

126,340,251 ordinary shares

 

The Company holds no ordinary shares in Treasury

Name of contact:

Ricardo Moura

Telephone number of contact:

+44 (0) 114 3039985

 

For further information, please contact:

 

Cirata Via FTI Consulting

Stephen Kelly, Chief Executive Officer

Ricardo Moura, Chief Financial Officer (Interim)

Daniel Hayes, Investor Relations

 

FTI Consulting +44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

 

Stifel (Nomad and Joint Broker) +44 (0)20 7710 7600

Fred Walsh / Brough Ransom / Ben Good / Sarah Wong

 

Panmure Liberum (Joint Broker) +44 (0)20 3100 2000

Max Jones / John More

 

About Cirata

Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRUOOORVNUNRAR
Date   Source Headline
30th Sep 20247:00 amRNSHCSC Contract Renewal
25th Sep 20247:00 amRNSAppointment of Interim CFO
19th Sep 202410:30 amRNSHolding(s) in Company
19th Sep 202410:30 amRNSHolding(s) in Company
4th Sep 20247:00 amRNSInterim results
31st Jul 20245:44 pmRNSHolding(s) in Company
31st Jul 20242:35 pmRNSDirector/PDMR Shareholding
26th Jul 20241:51 pmRNSHolding(s) in Company
19th Jul 20245:54 pmRNSDelay of Admission
17th Jul 20247:00 amRNSResult of Fundraising
16th Jul 20244:47 pmRNSPrimaryBid Offer
16th Jul 20244:46 pmRNSLaunch of Fundraise
16th Jul 20244:45 pmRNSQ2 Trading Update and Outlook
28th Jun 20248:00 amRNSBlock Listing Return
25th Jun 20247:08 amRNSGM Launches Phase 2
19th Jun 20247:00 amRNSTotal Voting Rights
21st May 20247:00 amRNSOPPO Contract Renewal
14th May 20243:28 pmRNSResult of Annual General Meeting
29th Apr 20245:01 pmRNSFurther re: Annual Report & Notice of AGM
24th Apr 20247:00 amRNSDirectorate Change
17th Apr 20243:05 pmRNSAnnual Report & Notice of AGM
9th Apr 20247:00 amRNSQ1 FY24 Trading Update
4th Apr 20247:00 amRNSFinal Results
6th Mar 20245:19 pmRNSHolding(s) in Company
4th Mar 20242:53 pmRNSHolding(s) in Company
21st Feb 20241:27 pmRNSHolding(s) in Company
15th Feb 20244:27 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSChair appointment
9th Jan 20247:00 amRNSTrading Update
4th Jan 20243:10 pmRNSTotal Voting Rights
4th Jan 20242:41 pmRNSHolding(s) in Company
3rd Jan 20245:40 pmRNSHolding(s) in Company
2nd Jan 20249:32 amRNSNotice of Q4 FY23 Trading Update
14th Dec 20236:12 pmRNSBlock Listing Application
12th Dec 20235:32 pmRNSGrant of Share Options to PDMRs
12th Dec 20238:29 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSTotal Voting Rights
5th Dec 202310:25 amRNSHolding(s) in Company
24th Nov 20235:40 pmRNSDirector/PDMR Shareholding
23rd Nov 202310:08 amRNSHolding(s) in Company
21st Nov 20235:41 pmRNSHolding(s) in Company
21st Nov 20231:28 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
17th Nov 20235:54 pmRNSDirector/PDMR Shareholding
8th Nov 20231:18 pmRNSHolding(s) in Company
7th Nov 20232:39 pmRNSTotal Voting Rights
2nd Nov 20237:00 amRNSChange of Auditor
27th Oct 20235:12 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSTrading Update and Outlook

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.